FRACTYL HEALTH/$GUTS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About FRACTYL HEALTH
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
- Ticker
- $GUTS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 100
- Headquarters
- Burlington, United States
- Website
- fractyl.com
FRACTYL HEALTH Metrics
BasicAdvanced
$14M
-
-$5.78
-
-
Price and volume
Market cap
$14M
52-week high
$4.81
52-week low
$0.80
Average daily volume
880K
Financial strength
Current ratio
1.979
Quick ratio
1.817
Long term debt to equity
-4.078
Total debt to equity
-4.505
Profitability
EBITDA (TTM)
-80.735
Management effectiveness
Return on assets (TTM)
-56.78%
Return on equity (TTM)
905.17%
Valuation
Price to book
-1.08
Price to tangible book (TTM)
-1.08
Price to free cash flow (TTM)
-0.184
Free cash flow yield (TTM)
-543.60%
Free cash flow per share (TTM)
-5.871
Growth
Earnings per share change (TTM)
-79.20%
3-year earnings per share growth (CAGR)
-77.37%
Upcoming events
No upcoming events
FRACTYL HEALTH News
AllArticlesVideos

GUTS CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Fractyl (NASDAQ: GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Business Wire4 weeks ago

GUTS DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Fractyl (GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Newsfile Corp1 month ago

GUTS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Fractyl (GUTS) Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
Newsfile Corp1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.